Recently, myelin oligodendrocyte glycoprotein (MOG) antibodies have been reported to encompass patients with varied pathologies involving the central nervous system, including optic neuritis (ON), acute disseminated encephalomyelitis, and encephalitis.[10–13]. This evidence concerns the gene MOG and optic neuritis.